Issued Patents 2022
Showing 1–17 of 17 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11517561 | Macrocycle and composition comprising thereof | Huanyin Li | 2022-12-06 |
| 11512074 | Substituted diamino heterocyclic carboxamide compound and a composition containing the compound and use thereof | Huanyin Li | 2022-11-29 |
| 11485729 | Substituted pyridazinone compound | Zhiqiang Liu | 2022-11-01 |
| 11459334 | Substituted pyrrolo[2,1-f][1,2,4]triazines as KIT and/or PDGFR-α inhibitors | Huanyin Li | 2022-10-04 |
| 11453672 | Substituted pyrazolo[1,5-a]pyrimidines as tropomyosin receptor kinase inhibitors | Jiuyang Zhao | 2022-09-27 |
| 11447512 | Antiviral nucleoside reverse transcriptase inhibitor | Jiuyang Zhao | 2022-09-20 |
| 11399840 | Implantable embolization device | Victoria Schuman, Zhimin Fang, Yapeng Xu, Haitao Cao, Zhipeng Chen +2 more | 2022-08-02 |
| 11389463 | Antiviral nucleoside reverse transcriptase inhibitor | Jiuyang Zhao | 2022-07-19 |
| 11384069 | Diphenylaminopyrimidine compound for inhibiting kinase activity | Huanyin Li | 2022-07-12 |
| 11358973 | Di(hetero)aryl macrocyclic compound for inhibiting protein kinase activity | Jiuyang Zhao, Yixin Ai | 2022-06-14 |
| 11345703 | Substituted pyrazolo[1,5-a]pyrimidine macrocyclic compound | Jiuyang Zhao | 2022-05-31 |
| 11319317 | (Hetero)arylamide compound for inhibiting protein kinase activity | Jiuyang Zhao, Yixin Ai | 2022-05-03 |
| 11301746 | Persona-driven and artificially-intelligent avatar | Ching-Yung Lin, Danny L. Yeh, Yizhou Shen, Yuting An, Xinwei Li | 2022-04-12 |
| 11267806 | Indazole compound for use in inhibiting kinase activity, composition and application thereof | Huanyin Li | 2022-03-08 |
| 11267810 | Aminopyrimidine compound and composition comprising same and use thereof | Huanyin Li | 2022-03-08 |
| D944370 | Mobile air conditioner | Chengye Huang, Huanlong Wu, Linjun Yu, Weirui Liu, Zhaoyang Wu +3 more | 2022-02-22 |
| 11254696 | Dianilinopyrimidine compound for inhibiting kinase activity | Huanyin Li | 2022-02-22 |